Immunopathology alters Th17 cell glucocorticoid sensitivity

J. Banuelos, Y. Cao, S. C. Shin, N. Z. Lu*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

48 Scopus citations

Abstract

Th17 cells contribute to several inflammatory conditions and increasing evidence supports that Th17 cells are glucocorticoid resistant. However, Th17 cells in psoriasis and related diseases are glucocorticoid sensitive. We compare glucocorticoid sensitive and resistant immunological diseases and suggest that several aspects in Th17-related diseases alter glucocorticoid sensitivity of Th17 cells. We identify molecular pathways that are implicated in glucocorticoid sensitivity of Th17 cells in the literature, as this information is useful for developing approaches to overcome glucocorticoid-resistant immunopathology.

Original languageEnglish (US)
Pages (from-to)331-341
Number of pages11
JournalAllergy: European Journal of Allergy and Clinical Immunology
Volume72
Issue number3
DOIs
StatePublished - Mar 1 2017

Funding

This study was funded by the National Institute of Allergy and Infectious Diseases, (R21AI113935), National Heart, Lung, and Blood Institute (R37HL068546), and the Ernest S. Bazley Foundation.

Keywords

  • Th17 cells
  • asthma
  • autoimmunity
  • glucocorticoid resistance
  • glucocorticoids

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Fingerprint

Dive into the research topics of 'Immunopathology alters Th17 cell glucocorticoid sensitivity'. Together they form a unique fingerprint.

Cite this